Sandoz, Others Settle Medicaid Inflation MDL Suits

Law360, New York (July 8, 2011, 8:45 PM EDT) -- Sandoz Inc. and other pharmaceutical companies on Friday settled part of a Massachusetts multidistrict litigation alleging the defendants caused the federal government to overpay for Medicaid reimbursements by reporting inflated drug values.

U.S. District Judge Patti B. Saris signed off on the Sandoz agreement as well as settlements involving Mylan Inc., Schein Pharmaceuticals Inc. and Watson Pharmaceuticals Inc., all of which put an end to litigation brought by Ven-A-Care of the Florida Keys Inc. as a relator for the federal government.

Judge Saris also approved a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.